1. Home
  2. STCN vs BOLD Comparison

STCN vs BOLD Comparison

Compare STCN & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STCN
  • BOLD
  • Stock Information
  • Founded
  • STCN 1986
  • BOLD 2018
  • Country
  • STCN United States
  • BOLD United States
  • Employees
  • STCN N/A
  • BOLD N/A
  • Industry
  • STCN Advertising
  • BOLD
  • Sector
  • STCN Consumer Discretionary
  • BOLD
  • Exchange
  • STCN Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • STCN 63.4M
  • BOLD 81.0M
  • IPO Year
  • STCN 1994
  • BOLD 2024
  • Fundamental
  • Price
  • STCN $10.40
  • BOLD $2.95
  • Analyst Decision
  • STCN
  • BOLD Strong Buy
  • Analyst Count
  • STCN 0
  • BOLD 3
  • Target Price
  • STCN N/A
  • BOLD $23.00
  • AVG Volume (30 Days)
  • STCN 11.9K
  • BOLD 57.8K
  • Earning Date
  • STCN 12-12-2024
  • BOLD 11-11-2024
  • Dividend Yield
  • STCN N/A
  • BOLD N/A
  • EPS Growth
  • STCN 203.29
  • BOLD N/A
  • EPS
  • STCN 3.17
  • BOLD N/A
  • Revenue
  • STCN $169,044,000.00
  • BOLD N/A
  • Revenue This Year
  • STCN N/A
  • BOLD N/A
  • Revenue Next Year
  • STCN N/A
  • BOLD N/A
  • P/E Ratio
  • STCN $3.19
  • BOLD N/A
  • Revenue Growth
  • STCN N/A
  • BOLD N/A
  • 52 Week Low
  • STCN $7.36
  • BOLD $2.82
  • 52 Week High
  • STCN $13.00
  • BOLD $15.24
  • Technical
  • Relative Strength Index (RSI)
  • STCN 57.19
  • BOLD N/A
  • Support Level
  • STCN $9.90
  • BOLD N/A
  • Resistance Level
  • STCN $10.29
  • BOLD N/A
  • Average True Range (ATR)
  • STCN 0.39
  • BOLD 0.00
  • MACD
  • STCN 0.11
  • BOLD 0.00
  • Stochastic Oscillator
  • STCN 100.00
  • BOLD 0.00

About STCN Steel Connect Inc.

Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: